Study: Winning an Early-Career Research Grant Begets More Funding

The relationship is independent of grantees’ scientific accomplishments.

Written byShawna Williams
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ladderISTOCK, BRIANAJACKSONGrant applicants who scored just below the funding threshold for an important early-career research award went on to win half as much grant money over the ensuing eight years than those who scored just above the threshold, according to a study published today (April 23) in PNAS. The differences in funding were partly explained by the fact that researchers who didn’t win an initial grant were less likely to apply for other funding opportunities, the study’s authors report.

“There is a group of very young talented scholars who have bad luck,” coauthor Thijs Bol of the University of Amsterdam tells Nature. “They do not get the same resources to bring their ideas to life.”

Bol and his colleagues sought empirical evidence for whether the so-called Matthew effect—in which initial success increases the chances of future successes—exists in academia. They analyzed early-career applicants for grants from the Netherlands Organization of Scientific Research, and later, mid-career applications by the same scientists, comparing the trajectories of grantees whose applications were rated just above the funding threshold to those of applicants who fell just short of the threshold.

Those who won an early-career grant were two and a half times more likely than their unsuccessful counterparts to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies